259 related articles for article (PubMed ID: 23574774)
1. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?
Netto GJ
Adv Anat Pathol; 2013 May; 20(3):175-203. PubMed ID: 23574774
[TBL] [Abstract][Full Text] [Related]
2. The role of imaging in the surveillance of urologic malignancies.
Bradford TJ; Montie JE; Hafez KS
Urol Clin North Am; 2006 Aug; 33(3):377-96. PubMed ID: 16829272
[TBL] [Abstract][Full Text] [Related]
3. [Tumor markers in urological malignancies].
Kuriyama M
Nihon Rinsho; 1996 Jun; 54(6):1631-6. PubMed ID: 8691621
[TBL] [Abstract][Full Text] [Related]
4. Inherited urologic malignant disorders: nursing implications.
Middelton L; Lessick M
Urol Nurs; 2003 Feb; 23(1):15-8, 23-9; quiz 30. PubMed ID: 12677717
[TBL] [Abstract][Full Text] [Related]
5. [Uronephrological and urogenital tumors: the urologist's viewpoint].
Leisinger HJ
Rev Med Suisse Romande; 1995 Mar; 115(3):227-8. PubMed ID: 7777761
[No Abstract] [Full Text] [Related]
6. [Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples].
Müller M; Goessl C; Krause H; Miller K
Urologe A; 2003 May; 42(5):660-8. PubMed ID: 12750801
[TBL] [Abstract][Full Text] [Related]
7. [Molecular biology advances and perspectives in urology].
Feria Bernal G; Arroyo Kuribreña JC
Rev Invest Clin; 2003; 55(2):243-7. PubMed ID: 12827935
[No Abstract] [Full Text] [Related]
8. Nucleic acid-based marker approaches to urologic cancers.
Veltri RW; Makarov DV
Urol Oncol; 2006; 24(6):510-27. PubMed ID: 17138133
[TBL] [Abstract][Full Text] [Related]
9. The role of methylation in urological tumours.
van der Heijden AG
Arch Esp Urol; 2013 Jun; 66(5):432-9. PubMed ID: 23793761
[TBL] [Abstract][Full Text] [Related]
10. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
11. [Advances in urologic oncology].
Boccon-Gibod L
Prog Urol; 1991 Feb; 1(1):17-21. PubMed ID: 1364643
[No Abstract] [Full Text] [Related]
12. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H; Hezova R; Stanik M; Slaby O
Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
[TBL] [Abstract][Full Text] [Related]
13. Tumor markers in urologic cancer.
Javadpour N
Urology; 1980 Aug; 16(2):127-36. PubMed ID: 6157242
[No Abstract] [Full Text] [Related]
14. Flow cytometry in urologic oncology.
Stephenson RA; Herr HW
Urol Clin North Am; 1986 Aug; 13(3):525-30. PubMed ID: 3523929
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of genito-urinary malignancies.
Cos LR; Caldamone AA; Frank IN
AUAA J; 1982; 3(1):4-8. PubMed ID: 6226266
[No Abstract] [Full Text] [Related]
16. Next-generation sequencing of urologic cancers: next is now.
Real FX; Boutros PC; Malats N
Eur Urol; 2014 Jul; 66(1):4-7. PubMed ID: 24731787
[TBL] [Abstract][Full Text] [Related]
17. [Significance of current bio- and molecular-markers in urological cancers].
Shimazui T; Akaza H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1008-14. PubMed ID: 15272577
[TBL] [Abstract][Full Text] [Related]
18. Theranostic and prognostic biomarkers: genomic applications in urological malignancies.
Netto GJ; Epstein JI
Pathology; 2010 Jun; 42(4):384-94. PubMed ID: 20438413
[TBL] [Abstract][Full Text] [Related]
19. [Multiple primary malignant neoplasms of the genitourinary system].
Musierowicz A; Ryszkiewicz B; Labedzki A; Rogowski W; Molenda W; Kubicz Z
Wiad Lek; 1985 Sep; 38(17):1213-6. PubMed ID: 4090494
[No Abstract] [Full Text] [Related]
20. [Diagnosis, therapy and prognosis of urologic tumors in the aged].
Guddat HM
Z Alternsforsch; 1985; 40(3):155-7. PubMed ID: 4013373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
